Nuformix plc Cash Flow Conversion Efficiency

Latest as of March 2026: -0.242x

Nuformix plc cash flow conversion efficiency. Based on the latest financial reports, Nuformix plc (NFX) has a cash flow conversion efficiency ratio of -0.242x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-395.35K ≈ $-48.10 USD) by net assets (GBX1.64 Million ≈ $199.11 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nuformix plc (2014–2025)

Cash flow conversion efficiency of Nuformix plc from 2014 to 2025. This chart illustrates how Nuformix plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NFX live share price for real-time trading data and today's change.

Nuformix plc Cash Flow Conversion Ratio Explained

Nuformix plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nuformix plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nuformix plc ranked by their cash flow conversion efficiency. Also see NFX market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
SpaceandPeople Plc LSE:SAL	0.008x
CULLINAN METALS CORP. F:7KO	0.017x
Empire Metals Limited LSE:GEO	-0.066x
Keras Resources PLC LSE:KRS	-0.132x
Union Jack Oil plc LSE:UJO	-0.019x
Gfinity PLC LSE:GFIN	-0.200x
KCR Residential Reit PLC LSE:KCR	-0.042x
Holdco Nuvo Group D.G Ltd NASDAQ:NUVOQ	N/A

Annual Cash Flow Conversion Efficiency for Nuformix plc (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nuformix plc from 2014 to 2025. Review NFX free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	GBX754.93K ≈ $91.85	GBX-614.61K ≈ $-74.78	-0.814x	-75.53%
2024-09-30	GBX715.57K ≈ $87.06	GBX-331.88K ≈ $-40.38	-0.464x	-256.20%
2023-09-30	GBX4.20 Million ≈ $510.41	GBX-546.23K ≈ $-66.46	-0.130x	-27.12%
2023-03-31	GBX4.23 Million ≈ $514.45	GBX-433.10K ≈ $-52.70	-0.102x	+63.94%
2022-03-31	GBX4.74 Million ≈ $576.47	GBX-1.35 Million ≈ $-163.73	-0.284x	-90.40%
2021-03-31	GBX5.69 Million ≈ $691.85	GBX-848.22K ≈ $-103.20	-0.149x	+2.77%
2020-03-31	GBX4.74 Million ≈ $577.03	GBX-727.60K ≈ $-88.53	-0.153x	-95.54%
2019-03-31	GBX3.82 Million ≈ $464.22	GBX-299.34K ≈ $-36.42	-0.078x	+76.98%
2018-03-31	GBX4.49 Million ≈ $546.69	GBX-1.53 Million ≈ $-186.31	-0.341x	-112.33%
2017-03-31	GBX-179.59K ≈ $-21.85	GBX-496.32K ≈ $-60.39	2.764x	+496.03%
2016-03-31	GBX502.34K ≈ $61.12	GBX-350.55K ≈ $-42.65	-0.698x	-89021.82%
2015-07-31	GBX-110.86K ≈ $-13.49	GBX86.80 ≈ $0.01	-0.001x	-224.10%
2014-07-31	GBX247.00K ≈ $30.05	GBX155.85 ≈ $0.02	0.001x	--

About Nuformix plc

LSE:NFX UK Biotechnology

Market Cap

$33.98K

GBX279.24 Million GBX

Market Cap Rank

#31730 Global

#1231 in UK

Share Price

GBX0.11

Change (1 day)

+1.90%

52-Week Range

GBX0.10 - GBX0.43

All Time High

GBX13.75